| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |